ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1407

Defining Thresholds of Presenteeism Measures for Unacceptable Work Participation in axSpA

Dafne Capelusnik1, Sofia Ramiro2, Elena Nikiphorou3, Walter P. Maksymowych4, Marina Nighat Magrey5, Helena Marzo-Ortega6 and Annelies Boonen7, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3King's College London, London, United Kingdom, 4University of Alberta, Edmonton, AB, Canada, 5Case Western Reserve University, University Hospitals, Cleveland, OH, 6NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

Meeting: ACR Convergence 2023

Keywords: Ankylosing spondylitis (AS), Disease Activity, Outcome measures, spondyloarthritis, work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Presenteeism is associated with lower work satisfaction and future sick leave in axial spondyloarthritis (axSpA). It is generally assessed as a continuous variable; however, despite a lower precision, categorical variables are more meaningful in routine practice.

Our objectives were: 1) To identify thresholds of presenteeism instruments that reflect unacceptable work status in patients with axSpA and whether those thresholds could predict future adverse work outcomes, 2) to compare the performance of these thresholds with thresholds from traditional outcomes for axSpA and 3) to understand whether thresholds are stable across contextual factors.

Methods: We used data from the 1-year multinational prospective study on Patient-Reported Outcomes in Employment Study in Ankylosing Spondylitis (AS-PROSE). Thresholds to determine when patients consider themselves in ‘unacceptable work status’ were calculated at baseline for 4 presenteeism instruments (Work Productivity and Activity Impairment questionnaire -WPAI-, Quality and Quantity method -QQ-, Workplace Activity Limitations Scale -WALS- and Work Limitations Questionnaire -WLQ 25-); and for BASDAI and BASFI.

We performed receiver operating characteristic (ROC) analysis using as external criteria the Patient Acceptable Work State (PAWS) question 1, addressing ability to perform your current job satisfactorily. We used different approaches (75th percentile, Youden index, Liu method, nearest to 0.1) to determine the optimal cut-off, while balancing over-under diagnosis. Temporal validation was assessed by applying the thresholds in different timepoints. Influence of context (age, gender, nature of work, symptom duration) was explored in subgroup analyses.

Finally, accuracy of thresholds to predict “future adverse work outcome” throughout 12 months (defined as sick leave or long-term disability) was assessed.

Results: A total of 366 patients were included: 72% males, mean age 43 (SD 10), with a mean symptom duration of 18.2 (11) years. 15% of the patients considered themselves in an unacceptable work status, and 6% had at least one adverse work outcome during the 12 months.

The optimal thresholds of the presenteeism instruments that reflect an unacceptable work status are expressed in the table. BASDAI and BASFI performed similarly to the presenteeism instruments (Figure). Across numerous contextual factors the thresholds were stable, expect for some underdiagnoses among women and persons with a physical loading job by WPAI-, QQ- , BASDAI- and BASFI-thresholds.

The threshold accuracy to predict adverse work outcome over 12 months was similar across all the presenteeism instruments (68-76% of correctly classified patients), except for the QQ (< 60%). BASDAI and BASFI also performed slightly worse (66-67%).

Conclusion: Thresholds for presenteeism and health status representing unacceptable work status have been established, showing stability across contextual factors. Threshold for QQ were insufficiently accurate and for BASDAI and BASFI were slightly worse although acceptable. The capacity of these thresholds to predict future adverse work outcome was somehow lower for all instruments.

Supporting image 1

Supporting image 2


Disclosures: D. Capelusnik: None; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, Galapagos, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, UCB Pharma, 2, 5; E. Nikiphorou: AbbVie/Abbott, 6, Celltrion, 6, Eli Lilly, 6, fresenius, 6, Galapagos, 6, Gilead, 1, 6, Pfizer, 6, Sanofi, 6; W. Maksymowych: AbbVie, 2, 5, 6, BMS, 2, 6, Boehringer-Ingelheim, 2, CARE Arthritis Ltd, 4, CARE Arthritis Ltd., 4, Celgene, 2, 6, Eli Lilly, 2, 6, Galapagos, 2, 6, Gilead, 2, Janssen, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6; M. Magrey: AbbVie, 2, Bristol Myers Squibb, 2, Eli Lilly, 2, Novartis, 2, Pfizer Inc, 2, UCB, 5; H. Marzo-Ortega: AbbVie, 2, 6, Biogen, 2, 6, Eli Lilly, 2, 6, Janssen, 2, 5, 6, MoonLake, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 6, Takeda, 2, 6, UCB Pharma, 2, 5, 6; A. Boonen: AbbVie, 2, 5, 6, Galapagos, 2, 6, Novartis, 2, 6, Pfizer, 5, 6, UCB Pharma, 2, 6.

To cite this abstract in AMA style:

Capelusnik D, Ramiro S, Nikiphorou E, Maksymowych W, Magrey M, Marzo-Ortega H, Boonen A. Defining Thresholds of Presenteeism Measures for Unacceptable Work Participation in axSpA [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/defining-thresholds-of-presenteeism-measures-for-unacceptable-work-participation-in-axspa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/defining-thresholds-of-presenteeism-measures-for-unacceptable-work-participation-in-axspa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology